← All trials
NCT02979691
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2016
- Primary completion
- Aug 1, 2020
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 385
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Chinese Academy of Medical SciencesLead sponsor
- Fujian Medical UniversityCollaborator
- Hebei UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Anyang Regional HospitalCollaborator
- Tianjin Medical UniversityCollaborator
- Chinese Academy of Medical SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.